EAGLE PHARMACEUTICALS INC's ticker is EGRX and the CUSIP is 269796108. A total of 126 filers reported holding EAGLE PHARMACEUTICALS INC in Q2 2023. The put-call ratio across all filers is 0.17 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2023 | $97,933 | -3.2% | 3,452 | -0.3% | 0.00% | 0.0% |
Q4 2022 | $101,194 | +4.3% | 3,462 | -5.8% | 0.00% | 0.0% |
Q3 2022 | $97,000 | -43.3% | 3,675 | -4.3% | 0.00% | -66.7% |
Q2 2022 | $171,000 | -20.5% | 3,842 | -11.5% | 0.00% | +50.0% |
Q1 2022 | $215,000 | -4.9% | 4,342 | -2.3% | 0.00% | 0.0% |
Q4 2021 | $226,000 | -16.9% | 4,442 | -9.0% | 0.00% | -33.3% |
Q3 2021 | $272,000 | +30.1% | 4,883 | 0.0% | 0.00% | +50.0% |
Q2 2021 | $209,000 | +2.5% | 4,883 | 0.0% | 0.00% | 0.0% |
Q1 2021 | $204,000 | -8.5% | 4,883 | +2.1% | 0.00% | -33.3% |
Q4 2020 | $223,000 | +29.7% | 4,783 | +17.8% | 0.00% | 0.0% |
Q3 2020 | $172,000 | -11.8% | 4,059 | 0.0% | 0.00% | 0.0% |
Q2 2020 | $195,000 | +4.3% | 4,059 | 0.0% | 0.00% | 0.0% |
Q1 2020 | $187,000 | -23.4% | 4,059 | 0.0% | 0.00% | 0.0% |
Q4 2019 | $244,000 | +1.2% | 4,059 | -4.7% | 0.00% | 0.0% |
Q3 2019 | $241,000 | +3.9% | 4,259 | +2.4% | 0.00% | 0.0% |
Q2 2019 | $232,000 | +7.9% | 4,159 | -2.3% | 0.00% | 0.0% |
Q1 2019 | $215,000 | +28.0% | 4,259 | +1.8% | 0.00% | 0.0% |
Q4 2018 | $168,000 | – | 4,182 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
JW Asset Management, LLC | 475,755 | $25,068,000 | 24.71% |
Hudson Executive Capital LP | 971,000 | $51,162,000 | 15.09% |
Park West Asset Management LLC | 1,051,274 | $55,392,000 | 2.47% |
U S GLOBAL INVESTORS INC | 19,200 | $1,012,000 | 0.62% |
Capital Impact Advisors, LLC | 26,317 | $1,387,000 | 0.57% |
CLARK ESTATES INC/NY | 56,278 | $2,965,000 | 0.47% |
IRIDIAN ASSET MANAGEMENT LLC/CT | 873,131 | $46,005,000 | 0.41% |
ProQuest Associates IV LLC | 6,777 | $357,000 | 0.41% |
Granite Investment Partners, LLC | 114,207 | $6,017,000 | 0.40% |
GLOBEFLEX CAPITAL L P | 30,900 | $1,628,000 | 0.34% |